As a technology-enabled clinical research services provider, "we" are dedicated to advancing medical science and improving healthcare outcomes through the integration of cutting-edge technology and rigorous research methodologies.

By leveraging technological innovations, data analytics, and scientific expertise, we aim to accelerate the discovery process, ensure patient safety, and enhance the overall efficiency of clinical research efforts. Our commitment lies in supporting pharmaceutical companies, biotechnology firms, and healthcare organizations in bringing novel treatments to market, ultimately benefiting patients worldwide.

CDKL5 deficiency disorder is a rare developmental epileptic encephalopathy caused by mutations in the CDKL5 gene, and this can manifest in a broad range of clinical symptoms and severity.

We are currently enrolling for an off-label prescription drug study for CDD.

Celerius CR is connected with a multinational integrated clinical trial site network. Through our extensive site and physician partnerships, we focus on large-volume recruitment of diverse, inclusive populations.

At Celerius Clinical Research, we establish a dummy data framework upfront, enabling easy substitution with live data from Case Report Forms (CRF). This approach ensures the smooth transformation of raw data into standardized SDTM datasets and then into ADaM datasets for statistical analysis. Our advanced tools generate detailed tables, listings, and figures (TLFs), compiled into comprehensive clinical study reports. By using this framework, we reduce timelines by 1.5x, enhancing efficiency while maintaining the highest quality standards in clinical trial reporting.